The 3 Best Retirement Stocks to Buy Now: September 2023

Stocks to buy

Building a well-rounded portfolio is crucial as you plan for financial stability in your retirement. Diversification is critical, ensuring your investments are spread across various sectors and asset types.  This has led to the rise of the best retirement stocks to buy.

Many retirement investors focus on dividend yield, as predictable income through retirement is vital to cash flow projections. But, while dividends can play a significant role in wealth growth, pay attention to the importance of solid fundamentals and growth prospects in the stocks you choose. 

These three retirement stocks meet the mark, offering sector diversification and continued financial stability – with decent dividend yield to boot. 

Caterpillar (CAT)

Source: Mike Mareen / Shutterstock

Caterpillar (NYSE:CAT) manufactures construction, mining, and other engineering equipment. With a dividend yield of 2.12% and an impressive track record of consistently raising dividends for 31 years, this stock has been a favorite among long-term and retirement investors.

 The stock is up 20% since January, beating earnings and revenue estimates in Q2. Caterpillar reported a 22% increase in revenues, which reached $17.3 billion. Earnings per share came in at $5.67, or $5.55 on an adjusted basis.

 Caterpillar’s position as the largest global construction and mining equipment manufacturer makes it a crucial barometer for the global economy’s health. More important for future prospects, though, is Caterpillar’s commitment to AI and automation. 13% of construction professionals use automation tools today, but 60% expect to do so in the future. 

Caterpillar is on the cutting edge of the industry with a suite of automated construction equipment, including self-digging solar ditch machines. Adaptability to emerging trends is key, and Caterpillar proves it has the foresight to capitalize on new tech and expand its market share.  This helps make it one of those best retirement stocks.

Investors looking for a blend of capital appreciation and steady income should consider Caterpillar a strategic addition to their portfolios, benefiting from its cyclical upswings and consistent dividend growth.

West Pharmaceutical Services (WST)

Source: Dmitry Kalinovsky / Shutterstock.com

West Pharmaceutical Services (NYSE:WST) specializes in designing and manufacturing injectable pharmaceutical packaging and delivery systems. The company offers a wide range of in-demand, essential products, including syringes, auto-injectors, and self-injection platforms.

Despite its modest 0.20% dividend yield, WST demonstrates impressive stock performance and returned a healthy 74% since January.

In its most recent earnings report, West Pharmaceutical Services exceeded analyst expectations. While net sales of $753.8 million showed a modest decline of 2.3%, organic net sales also decreased by 2.5%. Reported-diluted EPS came in at $2.06, down from $2.48 in the same period the previous year, but adjusted-diluted EPS amounted to $2.11, compared to $2.47 a year ago.

Despite these fluctuations, the company is optimistic about its future performance. West Pharmaceutical Services raised its full-year 2023 net sales guidance to $2.995 billion. That’s up a hair from the previous high of $2.990 billion. Additionally, the company revised its full-year 2023 adjusted-diluted EPS guidance to a new range of $7.65 to $7.80. The revision marks an improvement from the earlier range of $7.50 to $7.65. All in all, it’s one of those best retirement stocks to consider.

Investors seeking long-term growth for their retirement portfolio in the diversified pharmaceuticals packaging industry may find West Pharmaceutical Services an intriguing choice. Its long-term sustainability and in-demand products mean its future is assured, alongside management’s optimistic outlook.

Emerson Electric (EMR)

Source: ESB Professional / Shutterstock.com

Emerson Electric (NYSE:EMR) is a diversified company that manufactures products and offers engineering services across industrial, commercial, and consumer markets. While its stock has remained relatively flat this year, EMR is an attractive choice for income-focused investors. Today, the company offers a 2.3% dividend yield. But, more importantly to those focused on sustainable dividends, EMR raised its dividend for 66 consecutive years.

In its most recent earnings report, Emerson Electric beat analyst estimates by reporting quarterly earnings of $1.29 per share, lower than the previous year’s $1.38 per share. However, revenue figures came in at $3.95 billion, surpassing expectations. The company’s performance was affected by ongoing supply chain disruptions, a challenge faced by many players in the industry.

Due to their crucial role in supporting infrastructure, industrial stocks are known for their dependability. As a prominent player in global industrial automation, Emerson Electric plays a vital role in shaping the future of industrial processes and technologies.

Emerson offers stability through its consistent dividend history and is pivotal in the industrial automation sector. Tools within the sector remain essential for global infrastructure development. Emerson faces short-term challenges related to supply chain disruptions. Still, its strong track record and innovation make it a compelling option for investors adding industrials to their retirement portfolio.

On the date of publication, Jeremy Flint held no positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Jeremy Flint, an MBA graduate and skilled finance writer, excels in content strategy for wealth managers and investment funds. Passionate about simplifying complex market concepts, he focuses on fixed-income investing, alternative investments, economic analysis, and the oil, gas, and utilities sectors. Jeremy’s work can also be found at www.jeremyflint.work.

Articles You May Like

Behind the “Trump Bump”: How Much Could Stocks Rise in 2025?
BlackRock expands its tokenized money market fund to Polygon and other blockchains
AI’s Dark Horse Could Become Its Crown Jewel Under Trump
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
Market Watch: How Trump’s Tariff Strategy Could Reshape This Rally